If you’re in the US, is the Medtronic 630G really worth it?
If you take a look at the Facebook page for the Medtronic 640G, you’d be forgiven for thinking that the US has something similar available, […]
Month: September 2016
@OpenAPS – Standing on the shoulders of giants – #wearenotwaiting for an artificial pancreas!
loop /luːp/ verb 1. To monitor realtime glucose values and makes decisions to administer insulin accordingly. As I mentioned previously, I’d spent a fair amount […]
Comparing @OpenAPS and the Medtronic Hybrid Closed Loop System – what does the data say?
With the release yesterday of the Medtronic Hybrid Closed Loop pivotal study data, I thought it would be interesting to take a look at the […]
The SWITCH1 trial: Proving that Lantus/Basaglar has a higher Hypocglycaemia rate than Tresiba
Let’s start with the SWITCH 1 trial. What is it? It was a Phase 3a trial to compare the hypoglycaemia benefit of the two insulins. […]
Faster acting analogue insulin – straight from #EASD2016 – coming to a pharmacy near you, sometime….
The EASD Virtual Meeting place has been a revelation. It’s allowed me to view the sessions that I wanted the DOC that’s present at the […]
It’s EASD time again, and there’s a lot going down at the 52nd Annual Meeting
Gutted as I and many others of the GBDOC are to not be at the European Association for the Study of Diabetes (EASD) annual meeting […]
The great #gbdoc CGM debate – an alternative approach to NHS funding…
Following yesterday’s NNF conference on Continuous Glucose Monitoring (CGM) and the ensuing Twitter debate that frequently happens with these types of event, I gave some […]
Building myself an @openAPS DIY artificial pancreas, or how I spent my summer holiday…
Two weeks off work in Cornwall. A great time to sit in the sun and build an Artificial Pancreas. What an amazing world we live […]